2012PubMedRequires access

[Anticoagulants in the prevention of complications in patients with atrial fibrillation].

Skibitskiĭ Vv, Kanorskií Sg

Open publisher page 0 citations

Abstract

This review presents new data on the comparative effectiveness and safety of treatment with oral anticoagulants warfarin, dabigatran, rivaroxaban, apixaban for prevention of thromboembolism in patients with atrial fibrillation.

About this research paper

What this paper is about

This review presents new data on the comparative effectiveness and safety of treatment with oral anticoagulants warfarin, dabigatran, rivaroxaban, apixaban for prevention of thromboembolism in patients with atrial fibrillation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This review presents new data on the comparative effectiveness and safety of treatment with oral anticoagulants warfarin, dabigatran, rivaroxaban, apixaban for prevention of thromboembolism in patients with atrial fibrillation.

Key concepts: Atrial fibrillation, Cardiology, Medicine, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
[Anticoagulants in the prevention of complications in patients with atrial fibrillation]. — Research Paper | ScholarLens